4CL-46216-83276
3 vaccinations
1 coded response
39 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 981 / WA
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-20
Dose 1 — Pfizer-BioNTech
- 2021-03-20
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-29
- 2021-04-03
-
2021-04-10
Dose 2 — Pfizer-BioNTech
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-18
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-16
- 2021-05-22
- 2021-07-10
- 2021-10-09
-
2021-11-20
Dose 3 — Pfizer-BioNTech
- 2021-11-20
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint painsAdult check-in
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-12-04
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-01-01
- 2022-05-21
-
2022-11-22
Survey response — 12 months, dose 3MedDRA: Delivery — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Gave birthMedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-11-23
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2021-11-20 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-22 | Successful 2022-11-23 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 — 12 months, dose 3
Symptoms: Gave birth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release